Cederquist Kristina, Emanuelsson Monica, Göransson Ingela, Holinski-Feder Elke, Müller-Koch Yvonne, Golovleva Irina, Grönberg Henrik
Unit of Medical and Clinical Genetics, Department of Medical Biosciences, Umeå University, Sweden.
Int J Cancer. 2004 Apr 10;109(3):370-6. doi: 10.1002/ijc.11718.
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that predisposes to predominantly colorectal and endometrial cancers due to germline mutations in DNA mismatch repair genes, mainly MLH1, MSH2 and in families with excess endometrial cancer also MSH6. In this population-based study, we analysed the mutation spectrum of the MLH1, MSH2 and MSH6 genes in a cohort of patients with microsatellite unstable double primary tumours of the colorectum and the endometrium by PCR, DHPLC and sequencing. Fourteen of the 23 patients (61%) had sequence variants in MLH1, MSH2 or MSH6 that likely affect the protein function. A majority (10/14) of the mutations was found among probands diagnosed before age 50. Five of the mutations (36%) were located in MLH1, 3 (21%) in MSH2 and 6 (43%) in MSH6. MSH6 seem to have larger impact in our population than in other populations, due to a founder effect since all of the MSH6 families originate from the same geographical area. MSH6 mutation carriers have later age of onset of both colorectal cancer (62 vs. 51 years) and endometrial cancer (58 vs. 48 years) and a larger proportion of endometrial cancer than MLH1 or MSH2 mutation carriers. We can conclude that patients with microsatellite unstable double primary cancers of the colorectum and the endometrium have a very high risk of carrying a mutation not only in MLH1 or MSH2 but also in MSH6, especially if they get their first cancer diagnosis before the age of 50.
遗传性非息肉病性结直肠癌(HNPCC)是一种常染色体显性疾病,由于DNA错配修复基因(主要是MLH1、MSH2,在子宫内膜癌高发家族中还包括MSH6)的种系突变,易引发主要为结直肠癌和子宫内膜癌。在这项基于人群的研究中,我们通过聚合酶链反应(PCR)、变性高效液相色谱(DHPLC)和测序分析了一组患有微卫星不稳定型结直肠癌和子宫内膜双原发肿瘤患者的MLH1、MSH2和MSH6基因的突变谱。23例患者中有14例(61%)在MLH1、MSH2或MSH6中存在可能影响蛋白质功能的序列变异。大多数(10/14)突变出现在50岁之前确诊的先证者中。其中5个突变(36%)位于MLH1,3个(21%)位于MSH2,6个(43%)位于MSH6。由于所有MSH6家族都来自同一地理区域,存在奠基者效应,MSH6在我们的人群中似乎比在其他人群中有更大影响。与MLH1或MSH2突变携带者相比,MSH6突变携带者患结直肠癌(62岁对51岁)和子宫内膜癌(58岁对48岁)的发病年龄更晚,且子宫内膜癌的比例更高。我们可以得出结论,患有微卫星不稳定型结直肠癌和子宫内膜双原发癌的患者不仅在MLH1或MSH2,而且在MSH6中携带突变的风险非常高,尤其是如果他们在50岁之前首次被诊断出患有癌症。